Table 5. Summary of previous studies investigating the role of OPA1 polymorphisms in POAG.
| Studya | Population | Significant association | High-risk compound genotype (NTG) | |||||
|---|---|---|---|---|---|---|---|---|
| HTG | N = | NTG | N = | IVS8+4/+32 | Odds ratiob | 95% CI | ||
| [11,12] | Caucasian | No | 90 | Yes | 163 | CT/TC | 6.25 | 2.67-14.59 |
| [13] | Caucasian | N/A | - | Yes | 61 | CC/CC | 2.71 | 1.31-5.57 |
| [14] | Japanese | N/A | - | No | 337 | - | - | - |
| [15] | Korean | N/A | - | No | 65 | - | - | - |
| [24] | Indian | N/A | - | No | 50 | - | - | - |
| [24] | Chinese | N/A | - | No | 53 | - | - | - |
| [24] | Japanese | N/A | - | No | 42 | - | - | - |
| [25] | African-Caribbean | No | 48 | No | 61 | - | - | - |
| [23] | Japanese | No | 191 | Yes | 194 | CC/TC | 2.14 | 1.32-3.45 |
| [26] | Caucasian | No | 279 | N/A | - | - | - | - |
| [26] | African-American | No | 193 | N/A | - | - | - | - |
| [26] | African | No | 170 | N/A | - | - | - | - |
N/A: Not assessed; N: Number of patients analysed;
Studies in chronological order
Odds ratio were derived by χ2 analysis using published figures and additional unpublished data provided by Dr Vincent Raymond (Personal communication) for study [14].